A total of 16 patients (%) had hearing loss greater than 90 dB with an improvement rate of %; a total of 29 patients (%) had hearing loss of 90 dB or less and greater than to 50 dB with improvement rate of %; a total of 10 patients (%) had hearing loss less than 50 dB and greater than 30 dB with an improvement rate of % (Figure 3 ). Patients with severe losses greater than 90 dB had a poorer recovery (%) compared with losses less than 90 dB (%) ( 𝑃 = 0 . 0 6 Fisher’s test).
This is a very important and much underestimated aspect in the management of Menieres disease. This can help minimize stressors which act as a trigger to acute attacks, and can also help in the management of underlying tinnitus, dizziness and imbalance. A syndrome labeled psychophysiologic dizziness plays a large role in many patients with Meniere’s Disease. This essentially where an insult to the vestibular system leaves a degree of nerve damage. The brain needs to compensate for this loss and anxiety, especially anxiety centred on the fear of further attacks or dizziness can further amplify the symptoms of instability.
People who experience a sudden hearing loss (SSNHL) are often treated with systemic steroids, which are taken orally. Studies however show that people with sudden sensorineural hearing loss (SSNHL) who do not respond to this treatment can benefit from intratympanic steroid injections. Studies carried out at universities in USA and Thailand show intratympanic steroid injections to be very effective and that the treatment does not have any side-effects.
Dr. David Haynes from Vanderbilt University Medical Center, Nashville, USA, carried out the study of 40 people who had experienced sudden sensorineural hearing loss (SSNHL). Overall, 40% showed some kind of improvement when treated with intratympanic steroid injections.